Back to results
US 2009/0023779 A1Published application
Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
AssigneeLaboratoire Theramex
InventorsBenoit Rondot, Jean Lafay, Paule Bonnet, Thierry Clerc, Igor Duc, Eric Duranti, Francois Puccio, Jacqueline Shields, Christian Blot, Philippe Maillos
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula (I): in which R1, R2, R3, X, Y and A are as defined in the specification. The compounds are modulators of the estrogen receptors.
Claims20
A compound of formula (I)
- or an acid addition salt or a stereoisomeric form thereof,
- wherein:
- R1 is hydrogen or a (C1-C6)alkyl, (C3-C6)cycloalkyl, trifluoromethyl, —N═CR5R6, —SO2NR7R8, phenyl, phenyl(C1-C3)alkyl or (C1-C3)alkyl substituted by a saturated heterocyclic radical, wherein the phenyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy and a trifluoromethyl;
- R1 can also be a salt;
- R2 and R3 are each independently hydrogen or a hydroxyl, halogen, nitro, cyano, (C1-C6)alkyl, (C3-C6)cycloalkyl, (C1-C6)alkoxy, trifluoromethyl, —NR7R8, —CONR7R8, —COR9 or —CO2R9 group;
- R2 can also be a phenyl or a saturated or unsaturated heterocycle, wherein the phenyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy, a trifluoromethyl and a saturated heterocyclic radical;
- X is O, S, SO, SO2 or NR4;
- R4 is hydrogen or a (C1-C6)alkyl, (C3-C6)cycloalkyl, phenyl, phenyl(C1-C3)alkyl, (C1-C3)alkyl substituted by a saturated heterocyclic radical, —COR7, —CO2R7 or —SO2NR7R8 group, wherein the phenyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy, a trifluoromethyl, a phenyl(C1-C3)alkyl and a phenyl(C1-C3)alkoxy;
- Y is direct bond, O, S, SO, SO2, NR4, CO, —(CR10R11)n— or —R10C═CR11—;
- R5, R6, R7 and R8 are each independently hydrogen or a (C1-C6)alkyl or (C3-C6)cycloalkyl group;
- R9 is hydrogen, a (C1-C6)alkyl, a phenyl or a saturated or unsaturated heterocyclic radical, wherein the phenyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy, a trifluoromethyl and a saturated heterocyclic radical;
- R10 and R11 are each independently hydrogen or a cyano, (C1-C6)alkyl, —CO-phenyl, —CO(unsaturated heterocyclic radical) or —CONR7R8 group, wherein the phenyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy and a trifluoromethyl;
- n is 1 or 2;
- A is a (C3-C15)cycloalkyl, a (C3-C15)cycloalkene, a phenyl or a naphthyl, wherein the cycloalkyl or the cycloalkene is unsubstituted or substituted by at least one (C1-C6)alkyl, and wherein the phenyl or the naphthyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy and a trifluoromethyl;
- when X is NR4, Y and R2 together with the indazole ring bearing them can also form a 1H-pyrano[4,3,2-cd]indazole;
- provided that:
- 1/ when X is O, S or NR4, R1 is hydrogen or a (C1-C6)alkyl, (C3-C6)cycloalkyl or trifluoromethyl, and Y is a direct bond, then A is not optionally substituted phenyl or optionally substituted naphthyl;
- 2/ when X is NR4 where R4 is H or (C1-C6)alkyl and R1O is 6-OCH3, then Y is not CO;
- 3/ when X is O, R1O is 6-OH or 6-OCH3, Y is a direct bond and A is cyclopentyl, then (R2,R3) or (R3,R2) is different from (H, Cl) in position 4, 5;
- 4/ when X is O, R1O is 6-OH, R2 and R3 are H and Y is CH═CH, then A is not phenyl or 4-methoxyphenyl;
- 5/ When X is SO2, A is phenyl and R1O is 5- or 6-OCH3, then (R2,R3) or (R3,R2) is different from (H, OCH3) in position 6- or 5-.
18 more elements
Use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment of cognitive dysfunction:
- wherein:
- R1 is hydrogen or a (C1-C6)alkyl, (C3-C6)cycloalkyl, trifluoromethyl, —N═CR5R6, —SO2NR7R8, phenyl, phenyl(C1-C3)alkyl or (C1-C3)alkyl substituted by a saturated heterocyclic radical, wherein the phenyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy and a trifluoromethyl;
- R1 can also be a salt;
- R2 and R3 are each independently hydrogen or a hydroxyl, halogen, nitro, cyano, (C1-C6)alkyl, (C3-C6)cycloalkyl, (C1-C6)alkoxy, trifluoromethyl, —NR7R8, —CONR7R8, —COR9 or —CO2R9 group;
- R2 can also be a phenyl or a saturated or unsaturated heterocycle, wherein the phenyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy, a trifluoromethyl and a saturated heterocyclic radical;
- X is O, S, SO, SO2 or NR4;
- R4 is hydrogen or a (C1-C6)alkyl, (C3-C6)cycloalkyl, phenyl, phenyl(C1-C3)alkyl, (C1-C3)alkyl substituted by a saturated heterocyclic radical, —COR7, —CO2R7 or —SO2NR7R8 group, wherein the phenyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy, a trifluoromethyl, a phenyl(C1-C3)alkyl and a phenyl(C1-C3)alkoxy;
- Y is direct bond, O, S, SO, SO2, NR4, CO, —(CR10R11)n— or —R10C═CR11—;
- R5, R6, R7 and R8 are each independently hydrogen or a (C1-C6)alkyl or (C3-C6)cycloalkyl group;
- R9 is hydrogen, a (C1-C6)alkyl, a phenyl or a saturated or unsaturated heterocyclic, radical, wherein the phenyl is unsubstituted or substituted by at least one substitutent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy, a trifluoromethyl and a saturated heterocyclic radical;
- R10 and R11, are each independently hydrogen or a cyano, (C1-C6)alkyl, —CO-phenyl, —CO(unsaturated heterocyclic radical) or —CONR7R8 group, wherein the phenyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy and a trifluoromethyl;
- n is 1 or 2;
- A is a (C1-C6)alkyl, a (C3-C15)cycloalkyl, a (C3-C15)cycloalkene, a phenyl or a naphthyl, wherein the cycloalkyl or the cycloalkene is unsubstituted or substituted by at least one (C1-C6)alkyl, and wherein the phenyl or the naphthyl is unsubstituted or substituted by at least one substituent selected from the group consisting of a hydroxyl, a halogen, a nitro, a cyano, a (C1-C3)alkyl, a (C1-C3)alkoxy and a trifluoromethyl;
- when X is NR4, Y and R2 together with the indazole ring bearing them can also form a 1H-pyrano[4,3,2-cd]indazole;
- provided that when X is O, S or NR4, R1 is hydrogen or a (C1-C6)alkyl, (C3-C6)cycloalkyl or trifluoromethyl, and Y is a direct bond, then A is not optionally substituted phenyl or optionally substituted naphthyl.
12 more elements
Dependencies are inferred from the claim text.